Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002602945 | SCV003496433 | likely benign | not provided | 2024-02-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004935311 | SCV005615417 | uncertain significance | not specified | 2024-10-12 | criteria provided, single submitter | clinical testing | The c.1750G>A (p.A584T) alteration is located in exon 3 (coding exon 3) of the LZTS1 gene. This alteration results from a G to A substitution at nucleotide position 1750, causing the alanine (A) at amino acid position 584 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |